About the Journal
Focus and Scope
Progress in Nutrition was founded in 1999 as an independent magazine, a multidisciplinary approach, dedicated to issues of nutrition and metabolism. Official journal of the Italian Society of Nutritional Science (SISA) and sponsored by Nutrition and Food Researchers Association (ARNA). From 2001 is indexed by Excerpta Medica/Scopus, and from 2008 is indexed by Thomson-ISI: Science Citation Index Expanded (SciSearch®); Journal Citation Reports/Science Edition with Impact Factor.
The Journal publishes 4 issues for year: 1/2019 (March issue), 2/2019 (June issue), 3/2019 (September issue) and 4/2019 (December issue).
Peer Review Process
Progress in Nutrition employs double-blind review. Reviewers are unaware of the identity of the authors, and authors are also unaware of the identity of reviewers. There are at least three or more reviewers for the total number of articles in each issue.
Every manuscript is submitted at least to one Scientific Referees.These referees each return an evaluation of the work to the editor, noting weaknesses or problems along with suggestions for improvement. Typically, most of the referees' comments are eventually seen by the author. Reviewers remain anonymous to the authors. The Editor evaluates the referees' comments, her or his own opinion of the manuscript,and the context of the scope of the journal or level of the book and readership,before passing a decision back to the author(s),usually with the referees' comments.Referees' evaluations usually include an explicit recommendation of what to do with the manuscript or proposal. The role of the referees is advisory,and the editor is typically under no formal obligation to accept the opinions of the referees.
Focus of the Journal
From 2017 we don't accept any more and we don't publish articles about studies on rats or mice.
Instructions to submit a revised manuscript
Files you must have available:
- Revised manuscript file with changes highlighted or in red colour. In Word you can use Track Changes, then Highlight Changes or simply Underline your changes or use the red colour. Use a short file name, such as revised (the file extension should be added automatically), for your new manuscript file.
- File containing response to reviewers.
Please note that the Journal has change its policy and the publisher decided to introduce an article processing fee. The fee is due for all the articles submitted. Please, if you don't want to pay the fee, don't submit the article, and if you have already submitted, please, you should withdraw it. The new policy don't provide any waves or discounts. The discount/waiver requests will not be answered.
Starting from 1-1-2019, all submitted articles will have to pay a fee of 500 euro (for the articles submitted before 1st January 2019 the fee will be 250 euro). The fee should be paid after the acceptation of the article and before the publication.
All articles in Progress in Nutrition, like in all our journals, are open access immediately after their publication. This is thanks to an article processing fee that allows us to cover a series of publishing services we provide, such as online tools for authors, article production and hosting, direct relation with indexing services and customer services. This fee is to pay as soon as your manuscript is editorially accepted and before publication and it is charged to you or to your institution (or funder). The corresponding authors are responsible for making the payment or arranging it through their institutions. After that payment we proceed with the publication.
PRICE LIST (see also under the menu: About/Publication fee)
Publication fee: 500 Euro (for articles submitted from 1-1-2019 = 500 euro; submitted before 1-1-2019 = 250 euro).
Fast review + fast publication in the next available publishing issue: a) 1000 euro until 8 pages; b) 1400 euro from 9 pages to over.
The fee can be paid by paypal/credit card at Publication Fee form-Progress in Nutrition for articles submitted before 1st January 2019. Otherwise for articles submitted after 1st January 2019 the fee can be paid by paypal/credit card at Publication Fee form for submission in 2019
For other payment method: Bank transfer (enclosed copy) made out to:
Mattioli 1885 srl Strada di Lodesana 649/sx, Loc. Vaio, 43036 Fidenza (PR) -
Bank: Cariparma, Credit Agricole – Agenzia di Fidenza 3;
IBAN code: IT 39 S 06230 65732 000094186751 – Bic Code: CRPPIT2P487
Please, report in the transaction object the ID of the article and send copy (scan) to: firstname.lastname@example.org and cc: email@example.com
Please, download the "publication fee form" below to fill in and to re-send to: firstname.lastname@example.org and cc to: email@example.com
Policies on Conflict of Interest, Human and Animal rights, and Informed Consent
Progress in Nutrition requires authors to declare all competing interests in relation to their work. All submitted manuscripts must include a ‘competing interests’ section at the end of the manuscript listing all competing interests (financial and non-financial). Where authors have no competing interests, the statement should read “The authors have declared that no competing interests exist.” Editors may ask for further information relating to competing interests. Editors and reviewers are also required to declare any competing interests and will be excluded from the peer review process if a competing interest exists.
Competing interests may be financial or non-financial. A competing interest exists when the authors’ interpretation of data or presentation of information may be influenced by their personal or financial relationship with other people or organizations. Authors should disclose any financial competing interests but also any non-financial competing interests that may cause them embarrassment if they were to become public after the publication of the article.
Financial competing interests include (but are not limited to):
– Receiving reimbursements, fees, funding, or salary from an organization that may in any way gain or lose financially from the publication of the article, either now or in the future.
– Holding stocks or shares in an organization that may in any way gain or lose financially from the publication of the article, either now or in the future.
– Holding, or currently applying for, patents relating to the content of the manuscript.
– Receiving reimbursements, fees, funding, or salary from an organization that holds or has applied for patents relating to the content of the manuscript.
– Non-financial competing interests
– Non-financial competing interests include (but are not limited to) political, personal, religious, ideological, academic, and intellectual competing interests. If, after reading these guidelines, you are unsure whether you have a competing interest, please contact the Editor.
Authors from pharmaceutical companies, or other commercial organizations that sponsor clinical trials, should declare these as competing interests on submission. They should also adhere to the Good Publication Practice guidelines for pharmaceutical companies, which are designed to ensure that publications are produced in a responsible and ethical manner. The guidelines also apply to any companies or individuals that work on industry-sponsored publications, such as freelance writers, contract research organizations and communications companies.
Human and animal rights
All research must have been carried out within an appropriate ethical framework. If there is suspicion that work has not taken place within an appropriate ethical framework, Editors will follow the Misconduct policy and may reject the manuscript, and/or contact the author(s)’ institution or ethics committee. On rare occasions, if the Editor has serious concerns about the ethics of a study, the manuscript may be rejected on ethical grounds, even if approval from an ethics committee has been obtained.
Research involving human subjects, human material, or human data, must have been performed in accordance with the Declaration of Helsinki and must have been approved by an appropriate ethics committee. A statement detailing this, including the name of the ethics committee and the reference number where appropriate, must appear in all manuscripts reporting such research. If a study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript (including the name of the ethics committee that granted the exemption). Further information and documentation to support this should be made available to Editors on request. Manuscripts may be rejected if the Editor considers that the research has not been carried out within an appropriate ethical framework. In rare cases, Editors may contact the ethics committee for further information.
If a study has not been submitted to an ethics committee prior to commencing, retrospective ethics approval usually cannot be obtained and it may not be possible to consider the manuscript for peer review. How to proceed in such cases is at the Editor(s)’ discretion.
Authors reporting the use of a new procedure or tool in a clinical setting, for example as a technical advance or case report, must give a clear justification in the manuscript for why the new procedure or tool was deemed more appropriate than usual clinical practice to meet the patient’s clinical need. Such justification is not required if the new procedure is already approved for clinical use at the authors’ institution. Authors will be expected to have obtained ethics committee approval and informed patient consent for any experimental use of a novel procedure or tool where a clear clinical advantage based on clinical need was not apparent before treatment.
For all research involving human subjects, informed consent to participate in the study should be obtained from participants (or their parent or guardian in the case of children under 16) and a statement to this effect should appear in the manuscript.
For all manuscripts that include details, images, or videos relating to individual participants, written informed consent for the publication of these must be obtained from the participants (or their parent or legal guardian in the case of children under 16) and a statement to this effect should appear in the manuscript. If the participant has died, then consent for publication must be sought from the next of kin of the participant. This documentation must be made available to Editors on request, and will be treated confidentially. In cases where images are entirely unidentifiable and there are no details on individuals reported within the manuscript, consent for publication of images may not be required. The final decision on whether consent to publish is required lies with the Editor.
Experimental research on vertebrates or any regulated invertebrates must comply with institutional, national, or international guidelines, and where available should have been approved by an appropriate ethics committee. The Basel Declaration outlines fundamental principles to adhere to when conducting research in animals and the International Council for Laboratory Animal Science (ICLAS) has also published ethical guidelines.
A statement detailing compliance with relevant guidelines (e.g. the revised Animals (Scientific Procedures) Act 1986 in the UK and Directive 2010/63/EU in Europe) and/or ethical approval (including the name of the ethics committee and the reference number where appropriate) must be included in the manuscript. If a study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript (including the name of the ethics committee that granted the exemption and the reasons for the exemption). The Editor will take account of animal welfare issues and reserves the right to reject a manuscript, especially if the research involves protocols that are inconsistent with commonly accepted norms of animal research. In rare cases, Editors may contact the ethics committee for further information.
For experimental studies involving client-owned animals, authors must also document informed consent from the client or owner and adherence to a high standard (best practice) of veterinary care.
Field studies and other non-experimental research on animals must comply with institutional, national, or international guidelines, and where available should have been approved by an appropriate ethics committee. A statement detailing compliance with relevant guidelines and/or appropriate permissions or licences must be included in the manuscript. We recommend that authors comply with the Convention on the Trade in Endangered Species of Wild Fauna and Flora and the IUCN Policy Statement on Research Involving Species at Risk of Extinction.
Authors are strongly encouraged to conform to the Animal Research: Reporting In Vivo Experiments (ARRIVE) guidelines, developed by the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), for reporting animal studies.
For studies reporting livestock trials with production, health and food-safety outcomes, authors are encouraged to adhere to the Reporting Guidelines for Randomized Controlled Trials in Livestock and Food Safety (REFLECT).
Advertising Polices for Print and Web Publications
The mission of Mattioli 1885 is to provide a fast, reliable and thought-provoking media outlet to the world medical communities in both basic research and clinical practice, with timely coverage of diverse medical disciplinary topics.
The nature of all our journals are open access, which means all the contents of the journals are accessible freely to all viewers from every part of the world as long as they have internet accessibility, our viewers are from all over the world.
In addition to the contemporary online editions of journals, we also have print editions of journals circulating all over the world, this traditional media platform can meet different needs of our customers.
All advertising contents should be clearly indicated as an advertisement, they should not be confused with the editorial contents and articles. The editorial policy and publishing policy are not affected by any advertisers.
Our rates for advertising are very competitive, we can offer you prime advertising space for a very reasonable price. Our professional team can help you in each steps of advertising and strives to meet your need.
Submission of AD
Your may submit your advertisement in acceptable formats, or we can design your AD in an affordable rates, these rates are decided on a case-by-case basis.
Terms of advertising
All advertising contents are subject to the approval of the publisher. Advertised products should be legal and compliant with any national or international laws which may apply. AD placement or page/webpage positions can be requested but will not be guaranteed. Mattioli 1885 is not responsible for errors in advertisements following proof approval or self-submission.
The statements and opinions contained in the advertisement are solely those of the advertisers and do not necessarily reflect those of the editors or the publisher. The appearance of advertisements in the journals is not a warranty, endorsement or approval of the products or services advertised or of their safety. The editors and the Publisher disclaim responsibility for any injury to persons or property resulting from any ideas or productions referred to in the articles or advertisements.
ICMJE best practice standards
Mattioli 1885 requires the Authors and Editors of its journals to follow the recommendations by the International Committee of Medical Journal Editors (ICMJE), which reviews best practice and ethical standards in the conduct and reporting of research and other material published in medical journals. It is Mattioli 1885’ conviction that following these recommendations supports the accurate, clear, reproducible, and unbiased creation and distribution of scientific journal articles. Please download or review these recommendations here.
Corrections and retractions
Rarely, it may be necessary for Mattioli 1885 to publish [corrections] to, or [retractions] of, articles published in its journals, so as to maintain the integrity of the academic record.
In line with BioMed Central's [Permanency] policy, [corrections] to, or [retractions] of, published articles will be made by publishing an Erratum or a Retraction article, without altering the original article in any way other than to add a prominent link to the Erratum/Retraction article. The original article remains in the public domain and the subsequent Erratum or Retraction will be widely indexed. In the exceptional event that material is considered to infringe certain rights or is defamatory, we may have to remove that material from our site and archive sites.
It may be possible for minor corrections to published articles to be made by the original author(s) posting a comment on the published article. This would only be appropriate where the changes do not affect the results or conclusions of the article. See our [Comments] policy for further information on posting comments.
Changes to published articles that affect the interpretation and conclusion of the article, but do not fully invalidate the article, will, at the Editor(s)’ discretion, be corrected via publication of an Erratum that is indexed and linked to the original article. Changes in authorship of published articles are corrected via an Erratum..
On rare occasions, when the scientific information in an article is substantially undermined, it may be necessary for published articles to be retracted. Mattioli 1885 will follow the COPE guidelines in such cases. Retraction articles are indexed and linked to the original article.